A pooled SPYRAL HTN analysis (n = 2,137) showed sustained blood pressure reductions through 3 years after Symplicity Spyral renal denervation. A separate pooled analysis found a 42% reduction in ...

Salus Scientific Corporation, a developer of radiation protection garments and clinical workflow solutions for fluoroscopy-guided ...

Route 92 Medical, Inc. announced the commencement of the SUMMIT RISE postmarket study evaluating the performance of the company&rs ...

VS3 Medical, Inc. announced it has commenced enrollment in an international first-in-human (FIH) study evaluating the VS3 Med ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

We value keeping the Device Guide up to date.

With Timothy Fernandes, MD, MPH; Robert Lookstein, MD, MHCDL; Rachel P. Rosovsky, MD, MPH; Clay Wiske, MD; and Adam Reichard, MD ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

BD (Becton, Dickinson and Company) announced it has obtained CE Mark approval for the Revello vascular covered stent for the ...